Blog

I’m happy to send congratulations to my friend and colleague, Lisa Policare, CEO of Penn Wealth Planning on being recognized

Small privately-held companies will have new compliance burdens starting in the new year. The Federal Corporate Transparency Act (“CTA”) will

Bio NJ has some tremendous opportunities for C-suite executives at life sciences companies. Bio NJ has established a networking and

Here’s a great opportunity for those interested in biomedical research and entrepreneurship. The Biomedical Engineering Department at Stevens Institute of Technology

Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.

Losing one’s sight is one of the cruelest types of disabilities.  We depend on that sense for so much of